Inflammation both increases and causes resistance to FGF23 in normal and uremic rats

Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury

(2018) Luis Toro et al.   KIDNEY INTERNATIONAL

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

Differential regulation of renal Klotho and FGFR1 in normal and uremic rats

(2017) Juan R. Muñoz-Castañeda et al.   FASEB JOURNAL

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

(2016) Valentin David et al.   KIDNEY INTERNATIONAL

Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery

(2016) David E. Leaf et al.   KIDNEY INTERNATIONAL

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

(2015) Geoffrey A. Block et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients

(2015) Mark R. Hanudel et al.   PEDIATRIC NEPHROLOGY

Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease

(2014) Shunsuke Goto et al.   Clinical and Experimental Nephrology

Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD

(2013) T. Isakova et al.   Clinical Journal of the American Society of Nephrology

Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease

(2013) Shiqin Zhang et al.   KIDNEY INTERNATIONAL

Plasma FGF23 levels increase rapidly after acute kidney injury

(2013) Marta Christov et al.   KIDNEY INTERNATIONAL

Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification

(2013) Jane L. Finch et al.   KIDNEY INTERNATIONAL

FGF-23 Levels in Patients with AKI and Risk of Adverse Outcomes

(2012) D. E. Leaf et al.   Clinical Journal of the American Society of Nephrology

Fibroblast Growth Factor 23 and Inflammation in CKD

(2012) J. Munoz Mendoza et al.   Clinical Journal of the American Society of Nephrology

Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease

(2012) L. Darryl Quarles   EXPERIMENTAL CELL RESEARCH

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

(2012) Victoria Shalhoub et al.   JOURNAL OF CLINICAL INVESTIGATION

Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial

(2012) Mhairi Sigrist et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

FGF23 and PTH--double agents at the heart of CKD

(2012) J. Silver et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease

(2011) Guido Filler et al.   CLINICAL BIOCHEMISTRY

Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis

(2011) T. Isakova et al.   Clinical Journal of the American Society of Nephrology

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

The Inflammatory Cytokines TWEAK and TNF  Reduce Renal Klotho Expression through NF B

(2011) J. A. Moreno et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

(2011) Tamara Isakova et al.   KIDNEY INTERNATIONAL

The effect of vitamin D derivatives on vascular calcification associated with inflammation

(2011) F. Guerrero et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

(2011) E. Gonzalez-Parra et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study

(2011) MaryAnn Zhang et al.   Annals of Intensive Care

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

(2010) M. Wolf   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

(2010) Hisashi Hasegawa et al.   KIDNEY INTERNATIONAL

Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study

(2009) J. F. Navarro-Gonzalez et al.   Clinical Journal of the American Society of Nephrology

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

(2009) P. Manghat et al.   OSTEOPOROSIS INTERNATIONAL